SUNITINIB MALATE FDF

SUNITINIB MALATE FDF

Products

Information

Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sunitinib Malate. Indication: Kidney Cancer/ GIT Stromal Tumors. Pharmaceutical form: Capsules. Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg. Dossier status: EU filed.
Main Categories
Finished Dosage Forms (Products)
Supplied From
Malta
Medichem S.A.Medichem is a vertically integrated pharmacompan specialized in the development and manufacture of APIs and FDFs for the global generics industry. Our portfolio offers about 45 APIs and 20 FDFs, including highly potent products, as well as a wide range of services, ranging from R&D development to contract manufacturing and licensing. It is also a world leader in Chlorhexidine & Octenidine products. The group boasts of 50 years of experience in the sector, and guarantees the highest standards of quality, operational excellence and respect for the environmen...

Log in

See all the content and easy-to-use features by logging in or registering!